LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- LinkBio Corp.
- Study ID
- NCT06670651
- Status
- Enrolling By Invitation
Conditions
- Fracture
- Osteoarthritis (OA) of the Knee
- Rheumatoid Arthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 79 Years
- Healthy Volunteers
- Not accepted
Interventions
- total knee arthroplasty device — DEVICEtotal knee arthroplasty device with ultracongruent bearing surface
Study Details
To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.
Key Dates
- Start date
- Mar 21, 2025
- Status verified
- Apr 2025
- Primary completion
- Dec 31, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
Knee Injury and Osteoarthritis Outcome Score - Joint Replacement (KOOS-JR) - change from baseline [ Time Frame: 1 year postoperative ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OrthoAlabama Spine & Sports | Birmingham | Alabama | 35235 | - |
| Illinois Bone and Joint Institute | Libertyville | Illinois | 60048 | - |
Find similar trials in Birmingham, AL
By condition
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- ConsideRAte Study - Splenic Stimulation for RARecruiting · Galvani Bioelectronics · Anniston, Alabama